Kenvue Inc. (KVUE) - 5i Research

Kenvue Inc. (KVUE $14.37)
- $14.37 P/E (TTM): 18.99X Cap: $27.57B
- View KVUE Profile
- View Questions on KVUE

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Kenvue Inc. (KVUE $14.37)
- $14.37 P/E (TTM): 18.99X Cap: $27.57B
- View KVUE Profile
- View Questions on KVUE

Q: hi,

would appreciate your thoughts on Venue.

Thank you.

Read Answer Asked by Lorraine on September 25, 2025

Johnson & Johnson (JNJ $188.87)
- $188.87 P/E (TTM): 20.22X Cap: $454.86B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $862.86)
- $862.86 P/E (TTM): 55.2X Cap: $815.73B
- View LLY Profile
- View Questions on LLY
Kenvue Inc. (KVUE $14.37)
- $14.37 P/E (TTM): 18.99X Cap: $27.57B
- View KVUE Profile
- View Questions on KVUE

Q: I have held JNJ for years and I am *STILL* holding on , in the [vain] hope that surely management will FINALLY resolve its various self-inflicted legal problems. I have been MISERABLY wrong. JNJ shares continue to decline (drowning is the perception as we focus much more on loss). I was idiot enough to buy into JNJ’s spin off KVUE, on which I have a rather loss in just one year.

Notwithstanding the enthusiasm of media commentators, the health care sector hasn’t done anything outside of a couple of star-companies. Are JNJ and KVUE worth holding on to? I would appreciate very much your substance-backed reasons either way. In your answer, kindly please put less emphasis on the legal issues which are already well known and focus entirely on the future prospects .
Many thanks.

Read Answer Asked by Adam on June 21, 2024

Mondelez International Inc. (MDLZ $57.46)
- $57.46 P/E (TTM): 21.16X Cap: $74.14B
- View MDLZ Profile
- View Questions on MDLZ
Kenvue Inc. (KVUE $14.37)
- $14.37 P/E (TTM): 18.99X Cap: $27.57B
- View KVUE Profile
- View Questions on KVUE

Q: WHICH CONSUMER STOCK MONDELEZ OR KENVUE WOULD BE BETTER NOW AND GOING FORWARD FOR THE FUTURE?

Read Answer Asked by Herbert on October 02, 2023